Cargando…

AHCYL1 Is a Novel Biomarker for Predicting Prognosis and Immunotherapy Response in Colorectal Cancer

BACKGROUND: Colorectal cancer (CRC) is the third most frequent cancer worldwide. The AHCYL1 gene is required for CNV and has a close association with the tumor immune microenvironment. However, the predictive value of the AHCYL1 gene in patients with CRC remains unknown. METHODS: AHCYL1 gene with pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xubin, Zhang, Mengqiao, Yu, Xue, Xue, Mei, Li, Xiaowei, Ma, Chao, Jia, Wei, Gao, Qiang, Kang, Chunbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107370/ https://www.ncbi.nlm.nih.gov/pubmed/35578598 http://dx.doi.org/10.1155/2022/5054324

Ejemplares similares

Metabolomics analyses of cancer tissue from patients with colorectal cancer
por: Kang, Chunbo, et al.
Publicado: (2023)

Ahcyl2 upregulates NBCe1-B via multiple serine residues of the PEST domain-mediated association
por: Park, Pil Whan, et al.
Publicado: (2016)

S-adenosylhomocysteine hydrolase-like protein 1 (AHCYL1) inhibits lung cancer tumorigenesis by regulating cell plasticity
por: Muñoz-Bernart, Melina, et al.
Publicado: (2023)

Unbiased proteomic profiling reveals the IP3R modulator AHCYL1/IRBIT as a novel interactor of microtubule-associated protein tau
por: Wischhof, Lena, et al.
Publicado: (2022)

Correction: S-adenosylhomocysteine hydrolase-like protein 1 (AHCYL1) inhibits lung cancer tumorigenesis by regulating cell plasticity
por: Muñoz-Bernart, Melina, et al.
Publicado: (2023)

Increased NOX1 and DUOX2 expression in the colonic mucosa of patients with chronic functional constipation
por: Wei, Xiuqin, et al.
Publicado: (2022)

AHCYL1 Is Mediated by Estrogen-Induced ERK1/2 MAPK Cell Signaling and MicroRNA Regulation to Effect Functional Aspects of the Avian Oviduct
por: Jeong, Wooyoung, et al.
Publicado: (2012)

Hsa_circ_0002320: a novel clinical biomarker for colorectal cancer prognosis
por: Yang, Ning, et al.
Publicado: (2020)

Identification of the Thyrotropin-Releasing Hormone (TRH) as a Novel Biomarker in the Prognosis for Acute Myeloid Leukemia
por: Gao, Yan, et al.
Publicado: (2022)

Novel biomarkers for the diagnosis and prognosis of colorectal cancer
por: Oh, Hyung-Hoon, et al.
Publicado: (2020)

Novel Methylation Biomarkers for Colorectal Cancer Prognosis
por: Gutierrez, Alvaro, et al.
Publicado: (2021)

Impact of cytotoxic T lymphocytes immunotherapy on prognosis of colorectal cancer patients
por: Zhu, Yankun, et al.
Publicado: (2023)

ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer
por: Zhou, Jian-Kang, et al.
Publicado: (2017)

Identification of a Novel Ferroptosis-Related Gene Prediction Model for Clinical Prognosis and Immunotherapy of Colorectal Cancer
por: Yang, Ya-bing, et al.
Publicado: (2021)

Construction and validation of a novel angiogenesis pattern to predict prognosis and immunotherapy efficacy in colorectal cancer
por: Li, Zhiyong, et al.
Publicado: (2023)

The tumor immune microenvironment transcriptomic subtypes of colorectal cancer for prognosis and development of precise immunotherapy
por: Tang, Yun-Qiang, et al.
Publicado: (2020)

Exosomal Components and Modulators in Colorectal Cancer: Novel Diagnosis and Prognosis Biomarkers
por: Chang, Yu-Chan, et al.
Publicado: (2021)

SLC11A1 associated with tumor microenvironment is a potential biomarker of prognosis and immunotherapy efficacy for colorectal cancer
por: Ma, Yiming, et al.
Publicado: (2022)

Identification of Aging and Young Subtypes for Predicting Colorectal Cancer Prognosis and Immunotherapy Responses
por: Tan, Lulu, et al.
Publicado: (2023)

Biomarkers for Diagnosis, Prognosis and Response to Immunotherapy in Melanoma
por: Puglisi, Rossella, et al.
Publicado: (2021)

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer
por: Lin, Lijuan, et al.
Publicado: (2013)

PADI1 and Its Co-Expressed Gene Signature Unveil Colorectal Cancer Prognosis and Immunotherapy Efficacy
por: Zhang, Yi-ran, et al.
Publicado: (2022)

Systematic analysis of circRNA biomarkers for diagnosis, prognosis and therapy in colorectal cancer
por: Xiao, Yafei, et al.
Publicado: (2022)

Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers
por: Carlsen, Lindsey, et al.
Publicado: (2022)

Pancancer Analysis of Revealed TDO2 as a Biomarker of Prognosis and Immunotherapy
por: Cui, Jing, et al.
Publicado: (2022)

Role of TFRC as a Novel Prognostic Biomarker and in Immunotherapy for Pancreatic Carcinoma
por: Yang, Cheng, et al.
Publicado: (2022)

Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker
por: Tang, Yumei, et al.
Publicado: (2023)

Development of a novel hypoxia-immune–related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer
por: Luan, Likun, et al.
Publicado: (2022)

Novel inflammatory biomarkers in the prognosis of COVID-19
por: Zhan, Kegang, et al.
Publicado: (2023)

NMI: a potential biomarker for tumor prognosis and immunotherapy
por: He, Teng, et al.
Publicado: (2022)

ALOX12: A Novel Insight in Bevacizumab Response, Immunotherapy Effect, and Prognosis of Colorectal Cancer
por: Weng, Siyuan, et al.
Publicado: (2022)

A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer
por: Ge, Weiyu, et al.
Publicado: (2022)

A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma
por: Sun, Nan, et al.
Publicado: (2022)

Urotensin II receptor as a potential biomarker for the prognosis of hepatocellular carcinoma patients
por: Wei, Hongtao, et al.
Publicado: (2017)

The Efficacy of Percutaneous Transhepatic Gallbladder Drainage Combined with Gallbladder-Preserving Cholecystolithotomy in High-Risk Patients with Acute Calculous Cholecystitis
por: Kang, Chunbo, et al.
Publicado: (2022)

Combination of FOXD1 and Plk2: A novel biomarker for predicting unfavourable prognosis of colorectal cancer
por: Zong, Yaping, et al.
Publicado: (2022)

Predictive Potentials of ZEB1-AS1 in Colorectal Cancer Prognosis and Their Correlation with Immunotherapy
por: Ruan, Liqin, et al.
Publicado: (2022)

Assessment of POLE and POLD1 mutations as prognosis and immunotherapy biomarkers for stomach adenocarcinoma
por: Zhu, Mingyu, et al.
Publicado: (2022)

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021)

LncRNA LINC02257: A Potential Biomarker for Diagnosis and Prognosis of Colorectal Cancer
por: Chen, Mei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3lhmc5heb90adhnl2tnobhkfjk